Also for neuroblastoma, amplification of the MYCN gene, gain of 17q and loss of heterozygosity of chromosome 1 have been found to be recurring events, occurring extremely early in tumor development and remaining present during the course of the disease (41–43). Here, MYCN is linked to neoplasm.